Mitoxantrone in advanced breast cancer—a phase II study with special attention to cardiotoxicity
- 1 June 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (6) , 771-776
- https://doi.org/10.1016/0277-5379(84)90215-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Late Cardiac Effects of Therapeutic Mediastinal IrradiationNew England Journal of Medicine, 1983
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Anthracycline cardiotoxicity: Clinical and pathologic outcomes assessed by radionuclide ejection fractionCancer, 1980
- Combined chemotherapy and radiotherapy for locally advanced breast cancerPublished by Elsevier ,1980
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- Adriamycin and the HeartNew England Journal of Medicine, 1979
- Real-Time Radionuclide Cineangiography in the Noninvasive Evaluation of Global and Regional Left Ventricular Function at Rest and during Exercise in Patients with Coronary-Artery DiseaseNew England Journal of Medicine, 1977
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNAJournal of Pharmacy and Pharmacology, 1976